For example, the ubiquitin-binding protein CUEDC2 promotes ERα degradation via the proteasome pathway; consequently, malignant mammary tumors with high CUEDC2 expression under tamoxifen-resistant conditions exhibit low ERα levels (187). The gene discussed is ESR1; the disease is breast cancer.